Versigent (NYSE:VGNT – Get Free Report) released its quarterly earnings data on Wednesday. The company reported $1.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.79 by $0.12, Zacks reports.
Here are the key takeaways from Versigent’s conference call:
- Versigent reported 7% sales growth, 11% higher adjusted EBITDA, and 40 basis points of margin expansion; adjusted sales grew about 1% despite global automotive production declining approximately 2%. This marked its sixth consecutive quarter of growth over market.
- The company raised its 2026 free-cash-flow guidance to $275 million–$325 million, citing stronger year-to-date performance and the timing of some initiatives. The higher sales outlook reflects increased copper pass-throughs, while the adjusted EBITDA midpoint remains unchanged at $990 million.
- Versigent reported more than 115 program launches so far this year, with over 99% quality and on-time delivery, and secured $7.5 billion in year-to-date bookings. Management said the launches and awards demonstrate its ability to execute complex programs and support future growth.
- EMEA adjusted sales fell 8% amid weak demand, lower vehicle production, and program roll-offs. Elevated fourth-quarter launch activity and the lag in copper-cost recovery may also pressure sequential margins; management cautioned that third-quarter margins are not a new run rate.
- Adjacent markets such as battery energy storage, power generation, and robotics are generating early wins, but many programs remain in development or small-scale production. Management said these opportunities are not expected to contribute meaningfully to its current outlook.
Versigent Stock Up 4.3%
Shares of NYSE:VGNT traded up $1.75 on Wednesday, reaching $42.45. The company had a trading volume of 953,122 shares, compared to its average volume of 1,521,478. Versigent has a twelve month low of $26.34 and a twelve month high of $50.88. The company has a quick ratio of 1.09, a current ratio of 1.40 and a debt-to-equity ratio of 7.29. The stock has a market capitalization of $3.01 billion and a P/E ratio of 22.16. The stock has a 50-day moving average price of $45.18 and a 200 day moving average price of $42.71.
Analyst Upgrades and Downgrades
VGNT has been the topic of a number of research analyst reports. UBS Group decreased their target price on Versigent from $58.00 to $55.00 and set a “buy” rating on the stock in a research report on Thursday, July 9th. Evercore restated an “outperform” rating and set a $65.00 price objective on shares of Versigent in a report on Monday, August 10th. Fox Advisors cut Versigent from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, August 5th. Argus lifted their target price on Versigent from $50.00 to $54.00 and gave the stock a “buy” rating in a research report on Thursday, August 13th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $54.00 target price on shares of Versigent in a research note on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Versigent currently has a consensus rating of “Moderate Buy” and an average target price of $54.00.
Read Our Latest Research Report on VGNT
Insiders Place Their Bets
In other Versigent news, Director Kevin Clark sold 47,761 shares of the business’s stock in a transaction dated Thursday, October 8th. The shares were sold at an average price of $44.36, for a total value of $2,118,677.96. Following the transaction, the director directly owned 27,571 shares in the company, valued at $1,223,049.56. The trade was a 63.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders sold 220,000 shares of company stock worth $10,065,848 over the last 90 days.
About Versigent
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
See Also
- Five stocks we like better than Versigent
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
- Washington Made a $2 Billion Quantum Bet, But Can Either ETF Match It?
- Bloom Energy: The Off-Grid Answer to AI’s Power Drain
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
